February 11, 2015
Spellman DS et al. Prot Clin Appl 2015;9:715-731.
Development and Evaluation of a Multiplexed Mass Spectrometry-Based Assay for Measuring Candidate Peptide Biomarkers in Alzheimer’s Disease Neuroimaging Initiative (ADNI) CSF
You might also be interested by
Infographics
Supporting Your Targeted Protein Degradation Strategies
January 31, 2023
Proteomics/Mass Spectrometry
More infoCellTalk
Landmark study on metastatic breast cancer highlights the importance of identifying HER2-low patients
June 23, 2022
Proteomics/Mass Spectrometry
More infoPress Releases
CellCarta expands it proteomics portfolio with the acquisition of next-generation immuno-MRM assays from Precision Assays
May 19, 2022
Proteomics/Mass Spectrometry
More infoBrochures
High Performance Technologies for Cytokine Measurement
November 8, 2021
Immune Monitoring
More info